Ovary
Primary Site | Histology | Staging Type |
---|---|---|
C569 | 8000-8576, 8590-8671, 8930-9110 | TNM 7 and Summary Stage |
C569 | 8577-8589, 8672-8929, 9111-9136, 9141-9582, 9700-9701 | Summary Stage only |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C569 Ovary **Note 1:** This schema is based on the UICC chapter *Ovary,* pages 222-226. **Note 2:** Laterality must be coded for this site. **Note 3:** TNM values correspond to the stages accepted by the Federation Internationale de Gynecologic et d'Obstetrique (FIGO). * Note that FIGO uses a single stage value which corresponds to different groupings of T, N, and M values **Note 4:** The FIGO stages are based on surgical staging. (TNM stages are based on clinical and/or pathologic classification). **Note 5:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Ovary* chapter on page 212 of the [SS2000 on-line manual](https://seer.cancer.gov/tools/ssm/ssm2000/SSSM2000-122012.pdf#page=212).Main Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | <BLANK> | Yes |
NAACCR #940
tnmClinT |
None | |
Clinical N | <BLANK> | Yes |
NAACCR #950
tnmClinN |
None | |
Clinical M | <BLANK> | Yes |
NAACCR #960
tnmClinM |
None | |
TNM Clin Stage Group | 99 | Yes |
NAACCR #970
tnmClinStageGroup |
None | |
Pathologic T | <BLANK> | Yes |
NAACCR #880
tnmPathT |
None | |
Pathologic N | <BLANK> | Yes |
NAACCR #890
tnmPathN |
None | |
Pathologic M | <BLANK> | Yes |
NAACCR #900
tnmPathM |
None | |
TNM Path Stage Group | 99 | Yes |
NAACCR #910
tnmPathStageGroup |
None | |
SSF1: Carbohydrate Antigen 125 (CA-125) | 999 | No |
NAACCR #2880
csSiteSpecificFactor1 |
CCCR/Canada COC SEER |
None |
SSF2: FIGO Stage | 988 | No |
NAACCR #2890
csSiteSpecificFactor2 |
CCCR/Canada COC |
None |
SSF3: Residual Tumor Status and Size After Primary Cytoreduction Surgery | 999 | No |
NAACCR #2900
csSiteSpecificFactor3 |
CCCR/Canada COC SEER |
None |
SSF4: Tumor Location after Primary Cytoreduction (Debulking) Surgery | 988 | No |
NAACCR #2910
csSiteSpecificFactor4 |
None | None |
SSF5: Malignant Ascites | 988 | No |
NAACCR #2920
csSiteSpecificFactor5 |
None | None |
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No |
NAACCR #390
dateOfDiagnosis |
None | |
Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | Yes |
NAACCR #1639
rxSummSystemicSurSeq |
None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | Yes |
NAACCR #1380
rxSummSurgRadSeq |
None | |
Regional Nodes Positive | <BLANK> | Yes |
NAACCR #820
regionalNodesPositive |
None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | {{ctx_alg_version}} | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
derivedSeerClinStgGrp |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
derivedSeerPathStgGrp |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
derivedSeerCmbStgGrp |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
derivedSeerCombinedT |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
derivedSeerCombinedN |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
derivedSeerCombinedM |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
derivedSeerCmbTSrc |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
derivedSeerCmbNSrc |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
derivedSeerCmbMSrc |
None |